Diabetes and Hormonal Disorders
The Endocrinology and Diabetes Centre provides services involving management of growth, thyroid, pituitary, adrenal, pubertal and bone disorders.
The WCHN Endocrinology and Diabetes service provides a full range of endocrine/diabetes services for children from birth to 18 years of age and includes regional SA and interstate consultations.
Endocrine services include management of growth, thyroid, pituitary, adrenal, pubertal and bone disorders.
Diabetes services include initial stabilisation, child, adolescent and parent education at diagnosis and follow-up through the diabetes outpatient clinics, augmented by additional telehealth consultations.
How to access this service
Referrals from a health professional (e.g. General Practitioner or Paediatrician) is required for outpatient appointments. Medical practitioners are requested to consult the Endocrinology and Diabetes Referral Guidelines.
Making an appointment
Appointments for outpatient clinics can be made through the Outpatient Department on (08) 8161 7399. Appointments to see a consultant as a private patient can be made by calling (08) 8161 6402.
General Business: Monday to Friday, 9am – 5pm
Level 2, Zone C, Good Friday Building
(08) 8161 6402
(08) 8161 7759
Medical Unit Head, Endocrinology and Diabetes
- Dr Elaine Tham
- Clinical Lead Diabetes: Dr Jan Fairchild
- Clinical Lead Endocrinology: Dr Jenny Harrington
- Staff Specialists:
- Professor Jenny Couper
- Dr Jemma Anderson
- Dr Priya Augustine
- Dr Jessica Harbison
- Dr Alexia Pena
- Clinical Practice Consultant: Maree Thus
- Diabetes Educators:
- Shaun Johnson
- Tania Kelly
- Louise Wilson
- Clinical Practice Consultant: Kate Williams
- Rachel Battersby
- Annabel Crompton
- Stephanie Savio
The department houses a NHMRC JDRF Centre of Research Excellence in Type 1 Diabetes and is part of national and international immune therapy networks for the prevention of type 1 diabetes and its complications in children and adolescents, preservation of insulin production trials, trials of new insulin pump and glucose monitoring technologies, and the treatment of polycystic ovarian syndrome. We are also the state wide centre for counselling of families at risk of type 1 diabetes and we lead the national Environmental Determinants of Islet Autoimmunity study (ENDIA).